1084 — Green Fresh Biotechnology Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeSmall CapContrarian

Annual income statement for Green Fresh Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	Final	Final	Final
Revenue
Total Revenue	780	965	1,411	1,174	989
Cost of Revenue
Gross Profit	170	224	384	37.6	222
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	681	832	1,122	1,246	879
Operating Profit	99.7	133	289	-72.4	110
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	77.9	114	262	-113	80.9
Provision for Income Taxes
Net Income After Taxes	59.6	86.3	200	-85.4	60.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	61.3	86	199	-85.3	62.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	61.3	86	199	-85.3	62.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.075	0.108	0.24	-0.103	0.074
Dividends per Share